Today's full broadcast + interview:
Bright Videos News, Aug 6, 2026 - The Genetic Assault On Your Cells + Tech Privacy and Local AI with Hakeem From Above Phone
brightvideos.com/play/vid-d2eb

mFLUSIVA ADVERSE REACTIONS (Clinical Trials P304 & P303)

I asked my AI agents to research and find the list of side effects / adverse reactions on the new mFLUSIVA mRNA flu shot vaccine that the FDA just approved without adequate safety testing. Here's the list along with percentages, and these percentages are CRAZY high much higher rates of adverse reactions than I've ever seen in any vaccine...

And they didn't even bother using a placebo-controlled trial! They just compared the mRNA flu shot against a non-mRNA flu shot and called them both safe enough... (so much for "the science")...

Injection-Site Reactions (Local):
Pain - 65.8% (vs. 29.8% with standard-dose comparator)
Erythema (redness)
Swelling / induration (hardness)
Axillary (underarm) swelling or tenderness on the same side as the injection
Tenderness

Systemic Reactions:
Fatigue - 45.1% (vs. 20.3% comparator)
Headache - 37.8% (vs. 18.0% comparator)
Myalgia (muscle pain) - 35.4% (vs. 11.6% comparator)
Arthralgia (joint pain)
Chills
Nausea or vomiting
Fever

Severity Breakdown (Adults 65+ vs. Fluzone High-Dose, Study P303 Part C):
Any solicited local adverse reaction: 66.1% vs. 38.9%
Any solicited systemic adverse reaction: 61.3% vs. 32.9%
Grade 3 (severe) systemic reactions: 6.7% vs. 1.7%

Critical new article: If You Want to Live, Stop Trusting the FDA, CDC, Corporate Media, and Jab-Pushing Doctors
naturalnews.com/2026-08-05-sto



More News & Articles
Free Email Alerts
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.

NewsTarget.com © All Rights Reserved. All content posted on this site is commentary or opinion and is protected under Free Speech. NewsTarget.com is not responsible for content written by contributing authors. The information on this site is provided for educational and entertainment purposes only. It is not intended as a substitute for professional advice of any kind. NewsTarget.com assumes no responsibility for the use or misuse of this material. Your use of this website indicates your agreement to these terms and those published on this site. All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.

This site uses cookies
News Target uses cookies to improve your experience on our site. By using this site, you agree to our privacy policy.
Learn More
Close
Get 100% real, uncensored news delivered straight to your inbox
You can unsubscribe at any time. Your email privacy is completely protected.